Section Arrow
CORT.NASDAQ
- Corcept Therapeutics
Quotes are at least 15-min delayed:2025/07/21 06:57 EDT
Pre Market
Last
 71.14
+0.28 (+0.40%)
Bid
67
Ask
75
High 71.14 
Low 70.97 
Volume 36 
Regular Hours
Last
 70.86
-2.24 (-3.06%)
Day High 
73.5 
Prev. Close
73.1 
1-M High
77.42 
Volume 
563.10K 
Bid
67
Ask
75
Day Low
70.76 
Open
73.49 
1-M Low
66.49 
Market Cap 
7.75B 
Currency USD 
P/E 63.57 
%Yield -- 
10-SMA 71.29 
20-SMA 72.11 
50-SMA 72.52 
52-W High 117.33 
52-W Low 32.33 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.15/3.76
Enterprise Value
7.76B
Balance Sheet
Book Value Per Share
6.44
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
482.38M
Operating Revenue Per Share
4.24
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
Pre Market 1.97 -0.31 -13.60%
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
Pre Market 13 -1.075 -7.64%
NCNANuCana plc0.0477+0.0009+1.92%-- 
Pre Market 0.0474 -0.0003 -0.63%
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
Pre Market 6.23 +0.39 +6.68%
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Pre Market 6.11 +0.19 +3.21%
Quotes are at least 15-min delayed:2025/07/21 06:57 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.